Screening men for prostate cancer and colorectal cancer: is practice evidence-based?

Felix K H Chun, Nazareno Suardi, Paul Perrotte, Thierry Lebeau, Jean Pierre Guay, Serge Benayoun, Alvaro Ramirez, François Bénard, Michael McCormack, Luc Valiquette, Pierre Karakiewicz

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Controversy persists about whether men should be screened for prostate cancer. On the other hand, the benefit of colorectal cancer screening has been proven for men starting at age 50. We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec. MATERIALS AND METHODS: As part of an event promoting early prostate cancer detection, 347 men aged 50 to 69 without an established diagnosis of prostate cancer agreed to reply to questions in a previously validated questionnaire. The self-administered questionnaire, which asked about previous screening tests for prostate cancer and colorectal cancer, was completed on-site. RESULTS: Among men aged 50 to 69, previous exposure to a digital rectal examination (DRE), a prostate-specific antigen (PSA) test, a fecal occult blood test (FOBT), and sigmoidoscopy were reported by 132 men (62.9%), 73 men (34.8%), 37 men (17.6%), and 39 men (18.6%) , respectively. Across all age strata (<50, 50-69, > or = 70 years), PSA and DRE testing were highest in men aged 50 to 69 and were 2- to 3-fold higher than screening tests for colorectal cancer. CONCLUSIONS: In this cohort of asymptomatic Canadian men, overall and age-stratified exposure to tests to detect colon cancer early is far from ideal. Conversely, far more men have been subjected to PSA testing and DRE. Patients should be informed of the benefits and risks of colorectal cancer screening and PSA testing.

Original languageEnglish
Pages (from-to)3727-3733
Number of pages7
JournalThe Canadian journal of urology
Volume14
Issue number6
Publication statusPublished - Dec 2007

Fingerprint

Evidence-Based Practice
Colorectal Neoplasms
Prostatic Neoplasms
Prostate-Specific Antigen
Digital Rectal Examination
Early Detection of Cancer
Sigmoidoscopy
Occult Blood
Quebec
Hematologic Tests
Colonic Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chun, F. K. H., Suardi, N., Perrotte, P., Lebeau, T., Guay, J. P., Benayoun, S., ... Karakiewicz, P. (2007). Screening men for prostate cancer and colorectal cancer: is practice evidence-based? The Canadian journal of urology, 14(6), 3727-3733.

Screening men for prostate cancer and colorectal cancer : is practice evidence-based? / Chun, Felix K H; Suardi, Nazareno; Perrotte, Paul; Lebeau, Thierry; Guay, Jean Pierre; Benayoun, Serge; Ramirez, Alvaro; Bénard, François; McCormack, Michael; Valiquette, Luc; Karakiewicz, Pierre.

In: The Canadian journal of urology, Vol. 14, No. 6, 12.2007, p. 3727-3733.

Research output: Contribution to journalArticle

Chun, FKH, Suardi, N, Perrotte, P, Lebeau, T, Guay, JP, Benayoun, S, Ramirez, A, Bénard, F, McCormack, M, Valiquette, L & Karakiewicz, P 2007, 'Screening men for prostate cancer and colorectal cancer: is practice evidence-based?', The Canadian journal of urology, vol. 14, no. 6, pp. 3727-3733.
Chun FKH, Suardi N, Perrotte P, Lebeau T, Guay JP, Benayoun S et al. Screening men for prostate cancer and colorectal cancer: is practice evidence-based? The Canadian journal of urology. 2007 Dec;14(6):3727-3733.
Chun, Felix K H ; Suardi, Nazareno ; Perrotte, Paul ; Lebeau, Thierry ; Guay, Jean Pierre ; Benayoun, Serge ; Ramirez, Alvaro ; Bénard, François ; McCormack, Michael ; Valiquette, Luc ; Karakiewicz, Pierre. / Screening men for prostate cancer and colorectal cancer : is practice evidence-based?. In: The Canadian journal of urology. 2007 ; Vol. 14, No. 6. pp. 3727-3733.
@article{4df3963a9ae54fd0a76ba08437adf88a,
title = "Screening men for prostate cancer and colorectal cancer: is practice evidence-based?",
abstract = "INTRODUCTION: Controversy persists about whether men should be screened for prostate cancer. On the other hand, the benefit of colorectal cancer screening has been proven for men starting at age 50. We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec. MATERIALS AND METHODS: As part of an event promoting early prostate cancer detection, 347 men aged 50 to 69 without an established diagnosis of prostate cancer agreed to reply to questions in a previously validated questionnaire. The self-administered questionnaire, which asked about previous screening tests for prostate cancer and colorectal cancer, was completed on-site. RESULTS: Among men aged 50 to 69, previous exposure to a digital rectal examination (DRE), a prostate-specific antigen (PSA) test, a fecal occult blood test (FOBT), and sigmoidoscopy were reported by 132 men (62.9{\%}), 73 men (34.8{\%}), 37 men (17.6{\%}), and 39 men (18.6{\%}) , respectively. Across all age strata (<50, 50-69, > or = 70 years), PSA and DRE testing were highest in men aged 50 to 69 and were 2- to 3-fold higher than screening tests for colorectal cancer. CONCLUSIONS: In this cohort of asymptomatic Canadian men, overall and age-stratified exposure to tests to detect colon cancer early is far from ideal. Conversely, far more men have been subjected to PSA testing and DRE. Patients should be informed of the benefits and risks of colorectal cancer screening and PSA testing.",
author = "Chun, {Felix K H} and Nazareno Suardi and Paul Perrotte and Thierry Lebeau and Guay, {Jean Pierre} and Serge Benayoun and Alvaro Ramirez and Fran{\cc}ois B{\'e}nard and Michael McCormack and Luc Valiquette and Pierre Karakiewicz",
year = "2007",
month = "12",
language = "English",
volume = "14",
pages = "3727--3733",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "6",

}

TY - JOUR

T1 - Screening men for prostate cancer and colorectal cancer

T2 - is practice evidence-based?

AU - Chun, Felix K H

AU - Suardi, Nazareno

AU - Perrotte, Paul

AU - Lebeau, Thierry

AU - Guay, Jean Pierre

AU - Benayoun, Serge

AU - Ramirez, Alvaro

AU - Bénard, François

AU - McCormack, Michael

AU - Valiquette, Luc

AU - Karakiewicz, Pierre

PY - 2007/12

Y1 - 2007/12

N2 - INTRODUCTION: Controversy persists about whether men should be screened for prostate cancer. On the other hand, the benefit of colorectal cancer screening has been proven for men starting at age 50. We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec. MATERIALS AND METHODS: As part of an event promoting early prostate cancer detection, 347 men aged 50 to 69 without an established diagnosis of prostate cancer agreed to reply to questions in a previously validated questionnaire. The self-administered questionnaire, which asked about previous screening tests for prostate cancer and colorectal cancer, was completed on-site. RESULTS: Among men aged 50 to 69, previous exposure to a digital rectal examination (DRE), a prostate-specific antigen (PSA) test, a fecal occult blood test (FOBT), and sigmoidoscopy were reported by 132 men (62.9%), 73 men (34.8%), 37 men (17.6%), and 39 men (18.6%) , respectively. Across all age strata (<50, 50-69, > or = 70 years), PSA and DRE testing were highest in men aged 50 to 69 and were 2- to 3-fold higher than screening tests for colorectal cancer. CONCLUSIONS: In this cohort of asymptomatic Canadian men, overall and age-stratified exposure to tests to detect colon cancer early is far from ideal. Conversely, far more men have been subjected to PSA testing and DRE. Patients should be informed of the benefits and risks of colorectal cancer screening and PSA testing.

AB - INTRODUCTION: Controversy persists about whether men should be screened for prostate cancer. On the other hand, the benefit of colorectal cancer screening has been proven for men starting at age 50. We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec. MATERIALS AND METHODS: As part of an event promoting early prostate cancer detection, 347 men aged 50 to 69 without an established diagnosis of prostate cancer agreed to reply to questions in a previously validated questionnaire. The self-administered questionnaire, which asked about previous screening tests for prostate cancer and colorectal cancer, was completed on-site. RESULTS: Among men aged 50 to 69, previous exposure to a digital rectal examination (DRE), a prostate-specific antigen (PSA) test, a fecal occult blood test (FOBT), and sigmoidoscopy were reported by 132 men (62.9%), 73 men (34.8%), 37 men (17.6%), and 39 men (18.6%) , respectively. Across all age strata (<50, 50-69, > or = 70 years), PSA and DRE testing were highest in men aged 50 to 69 and were 2- to 3-fold higher than screening tests for colorectal cancer. CONCLUSIONS: In this cohort of asymptomatic Canadian men, overall and age-stratified exposure to tests to detect colon cancer early is far from ideal. Conversely, far more men have been subjected to PSA testing and DRE. Patients should be informed of the benefits and risks of colorectal cancer screening and PSA testing.

UR - http://www.scopus.com/inward/record.url?scp=41949097805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949097805&partnerID=8YFLogxK

M3 - Article

C2 - 18163923

AN - SCOPUS:41949097805

VL - 14

SP - 3727

EP - 3733

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 6

ER -